Publication Information

{'id': 'https://openalex.org/W1994627117', 'doi': 'https://doi.org/10.1007/s40262-014-0132-7', 'title': 'Population Pharmacokinetics and Prediction of Dopamine D2 Receptor Occupancy After Multiple Doses of RBP‐7000, a New Sustained‐Release Formulation of Risperidone, in Schizophrenia Patients on Stable Oral Risperidone Treatment', 'display_name': 'Population Pharmacokinetics and Prediction of Dopamine D2 Receptor Occupancy After Multiple Doses of RBP‐7000, a New Sustained‐Release Formulation of Risperidone, in Schizophrenia Patients on Stable Oral Risperidone Treatment', 'publication_year': 2014, 'publication_date': '2014-01-23', 'ids': {'openalex': 'https://openalex.org/W1994627117', 'doi': 'https://doi.org/10.1007/s40262-014-0132-7', 'mag': '1994627117', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/24464285'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1007/s40262-014-0132-7', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S69290020', 'display_name': 'Clinical Pharmacokinetics', 'issn_l': '0312-5963', 'issn': ['0312-5963', '1179-1926'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320330', 'host_organization_name': 'Adis, Springer Healthcare', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310320330'], 'host_organization_lineage_names': ['Springer Nature', 'Adis, Springer Healthcare'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5030198338', 'display_name': 'Céline M. Laffont', 'orcid': 'https://orcid.org/0000-0001-8345-5980'}, 'institutions': [], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Celine M. Laffont', 'raw_affiliation_strings': ['Pharmacometrica, La Fouillade, France'], 'affiliations': [{'raw_affiliation_string': 'Pharmacometrica, La Fouillade, France', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5087777889', 'display_name': 'Roberto Goméni', 'orcid': 'https://orcid.org/0000-0003-3916-9578'}, 'institutions': [{'id': 'https://openalex.org/I1309191912', 'display_name': 'Research Triangle Park Foundation', 'ror': 'https://ror.org/03eqttr49', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I1309191912']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Roberto Gomeni', 'raw_affiliation_strings': ['Alleantis, Research Triangle Park, USA'], 'affiliations': [{'raw_affiliation_string': 'Alleantis, Research Triangle Park, USA', 'institution_ids': ['https://openalex.org/I1309191912']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101743317', 'display_name': 'Bo Zheng', 'orcid': 'https://orcid.org/0000-0001-8576-1367'}, 'institutions': [{'id': 'https://openalex.org/I4210125531', 'display_name': 'Reckitt Benckiser (United States)', 'ror': 'https://ror.org/030893n97', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210115825', 'https://openalex.org/I4210125531']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bo Zheng', 'raw_affiliation_strings': ['Reckitt Benckiser Pharmaceuticals, Inc., Richmond, USA'], 'affiliations': [{'raw_affiliation_string': 'Reckitt Benckiser Pharmaceuticals, Inc., Richmond, USA', 'institution_ids': ['https://openalex.org/I4210125531']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040807522', 'display_name': 'Christian Heidbreder', 'orcid': 'https://orcid.org/0000-0001-8937-003X'}, 'institutions': [{'id': 'https://openalex.org/I4210125531', 'display_name': 'Reckitt Benckiser (United States)', 'ror': 'https://ror.org/030893n97', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210115825', 'https://openalex.org/I4210125531']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christian Heidbreder', 'raw_affiliation_strings': ['Reckitt Benckiser Pharmaceuticals, Inc., Richmond, USA'], 'affiliations': [{'raw_affiliation_string': 'Reckitt Benckiser Pharmaceuticals, Inc., Richmond, USA', 'institution_ids': ['https://openalex.org/I4210125531']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069195027', 'display_name': 'Paul J. Fudala', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210125531', 'display_name': 'Reckitt Benckiser (United States)', 'ror': 'https://ror.org/030893n97', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210115825', 'https://openalex.org/I4210125531']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Paul J. Fudala', 'raw_affiliation_strings': ['Reckitt Benckiser Pharmaceuticals, Inc., Richmond, USA'], 'affiliations': [{'raw_affiliation_string': 'Reckitt Benckiser Pharmaceuticals, Inc., Richmond, USA', 'institution_ids': ['https://openalex.org/I4210125531']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5034593787', 'display_name': 'Azmi Nasser', 'orcid': 'https://orcid.org/0000-0003-0514-8410'}, 'institutions': [{'id': 'https://openalex.org/I4210125531', 'display_name': 'Reckitt Benckiser (United States)', 'ror': 'https://ror.org/030893n97', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210115825', 'https://openalex.org/I4210125531']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Azmi F. Nasser', 'raw_affiliation_strings': ['Reckitt Benckiser Pharmaceuticals, Inc., Richmond, USA'], 'affiliations': [{'raw_affiliation_string': 'Reckitt Benckiser Pharmaceuticals, Inc., Richmond, USA', 'institution_ids': ['https://openalex.org/I4210125531']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 2.493, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 28, 'citation_normalized_percentile': {'value': 0.999917, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 92, 'max': 93}, 'biblio': {'volume': '53', 'issue': '6', 'first_page': '533', 'last_page': '543'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10023', 'display_name': 'Schizophrenia research and treatment', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10023', 'display_name': 'Schizophrenia research and treatment', 'score': 0.9988, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12229', 'display_name': 'Pharmacological Effects and Toxicity Studies', 'score': 0.9987, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12547', 'display_name': 'Pharmaceutical studies and practices', 'score': 0.9978, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/pharmacotherapy', 'display_name': 'Pharmacotherapy', 'score': 0.53652847}], 'concepts': [{'id': 'https://openalex.org/C2780057945', 'wikidata': 'https://www.wikidata.org/wiki/Q412443', 'display_name': 'Risperidone', 'level': 3, 'score': 0.91582537}, {'id': 'https://openalex.org/C2776412080', 'wikidata': 'https://www.wikidata.org/wiki/Q7431605', 'display_name': 'Schizophrenia (object-oriented programming)', 'level': 2, 'score': 0.5998386}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.59332603}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5737325}, {'id': 'https://openalex.org/C44208683', 'wikidata': 'https://www.wikidata.org/wiki/Q15335165', 'display_name': 'Dopamine receptor D2', 'level': 3, 'score': 0.54521286}, {'id': 'https://openalex.org/C500440147', 'wikidata': 'https://www.wikidata.org/wiki/Q701216', 'display_name': 'Pharmacotherapy', 'level': 2, 'score': 0.53652847}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.47062778}, {'id': 'https://openalex.org/C2908647359', 'wikidata': 'https://www.wikidata.org/wiki/Q2625603', 'display_name': 'Population', 'level': 2, 'score': 0.46269757}, {'id': 'https://openalex.org/C513476851', 'wikidata': 'https://www.wikidata.org/wiki/Q170304', 'display_name': 'Dopamine', 'level': 2, 'score': 0.38531527}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.35249385}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.32216415}, {'id': 'https://openalex.org/C99454951', 'wikidata': 'https://www.wikidata.org/wiki/Q932068', 'display_name': 'Environmental health', 'level': 1, 'score': 0.09157497}], 'mesh': [{'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D017448', 'descriptor_name': 'Receptors, Dopamine D2', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000284', 'descriptor_name': 'Administration, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D003692', 'descriptor_name': 'Delayed-Action Preparations', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007279', 'descriptor_name': 'Injections, Subcutaneous', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007555', 'descriptor_name': 'Isoxazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007555', 'descriptor_name': 'Isoxazoles', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008954', 'descriptor_name': 'Models, Biological', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068882', 'descriptor_name': 'Paliperidone Palmitate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D017448', 'descriptor_name': 'Receptors, Dopamine D2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D055815', 'descriptor_name': 'Young Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1007/s40262-014-0132-7', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S69290020', 'display_name': 'Clinical Pharmacokinetics', 'issn_l': '0312-5963', 'issn': ['0312-5963', '1179-1926'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320330', 'host_organization_name': 'Adis, Springer Healthcare', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310320330'], 'host_organization_lineage_names': ['Springer Nature', 'Adis, Springer Healthcare'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/24464285', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.72, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 21, 'referenced_works': ['https://openalex.org/W1598068766', 'https://openalex.org/W1864525495', 'https://openalex.org/W1906145619', 'https://openalex.org/W1967318659', 'https://openalex.org/W1972676137', 'https://openalex.org/W2006583270', 'https://openalex.org/W2021635654', 'https://openalex.org/W2029995473', 'https://openalex.org/W2039192863', 'https://openalex.org/W2047151451', 'https://openalex.org/W2050173051', 'https://openalex.org/W2054168994', 'https://openalex.org/W2064828122', 'https://openalex.org/W2095519765', 'https://openalex.org/W2112640060', 'https://openalex.org/W2162391751', 'https://openalex.org/W2267542151', 'https://openalex.org/W2292125616', 'https://openalex.org/W2582743722', 'https://openalex.org/W2693864954', 'https://openalex.org/W4285719527'], 'related_works': ['https://openalex.org/W3146305876', 'https://openalex.org/W2385608234', 'https://openalex.org/W2379257132', 'https://openalex.org/W2361037870', 'https://openalex.org/W2347881328', 'https://openalex.org/W2074818354', 'https://openalex.org/W2050162510', 'https://openalex.org/W2020249494', 'https://openalex.org/W1982143310', 'https://openalex.org/W1973248478'], 'abstract_inverted_index': None, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1994627117', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 5}, {'year': 2020, 'cited_by_count': 4}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 3}, {'year': 2016, 'cited_by_count': 4}, {'year': 2015, 'cited_by_count': 2}, {'year': 2014, 'cited_by_count': 2}], 'updated_date': '2024-12-10T07:01:28.890442', 'created_date': '2016-06-24'}